Physician profile
Ranbir Singh
NPI 1720548985
$2,085.73
in general payments reported to CMS, 2019-2025
12 companies · $1,875 in 2025
The $1,875 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.69 · 2023: $94.42 · 2024: $94.63 · 2025: $1,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,919 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,918.91 |
| Education | $145.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $632.45 | 2024-2025 | Dragonfly Opstar, Ensite, Perclose Prostyle |
| Abiomed | $426.23 | 2025 | |
| Medtronic, INC. | $242.16 | 2025 | Symplicity G3, Corevalve Evolut R |
| Boston Scientific Corporation | $239.16 | 2025 | Avvigo Guidance System, Eluvia, Sentinel |
| Bard Peripheral Vascular, INC. | $146.82 | 2025 | Rotarexs 6 F X 135 Cm, Dorado, Lutonix Drug Coated Balloon |
| Teleflex LLC | $119.54 | 2025 | Orsiro Mission |
| Pfizer INC. | $103.18 | 2021-2023 | |
| Chiesi USA, INC. | $73.53 | 2025 | Kengreal |
| Getinge USA Sales, LLC | $39.09 | 2025 | Vasoview Hemopro 2 |
| Lantheus Medical Imaging, INC. | $26.01 | 2024 | |
| W. L. Gore & Associates, INC. | $24.63 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| E.R. Squibb & Sons, L.L.C. | $12.93 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranbir Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.